Technology | Interventional Radiology | August 14, 2019

New application follows previous clearance of optical coherence tomography system for esophageal applications

FDA Clears NvisionVLE Imaging System for Pancreatic and Biliary Applications

Image courtesy of NinePoint Medical


August 14, 2019 — NinePoint Medical Inc. announced it has received U.S. Food and Drug Administration (FDA) clearance to market the NvisionVLE Imaging System for use in the pancreas and bile duct. These anatomical indications add to the previously existing esophageal applications for NinePoint’s optical coherence tomography (OCT) imaging platform.

The NvisionVLE Imaging System provides physicians real-time, high-resolution volumetric images of the tissue surface and subsurface. This allows gastroenterologists to thoroughly evaluate tissue for regions of interest that may not be visible with other medical imaging technologies. The newly cleared application is associated with NinePoint’s Low-Profile Optical Probe, a 7 French diameter imaging probe designed to handle small and tortuous anatomies, such as those found in the pancreatico-biliary system. In the pancreas and bile duct, the ability to see beneath the tissue surface could help physicians answer a number of important clinical questions.

“When a patient enters our care with an undiagnosed condition in the pancreatico-biliary system, the stakes can be very high,” said Isaac Raijman, M.D., previously the chief of gastroenterology at Baylor St. Luke’s Medical Center. “We have a number of tools today to help evaluate a patient’s condition within this anatomy. Unfortunately in many cases, our current toolset is unable to provide enough information to determine the best course of action. This is especially concerning for strictures or blockages of unknown origin. We are hopeful and excited that imaging beneath the surface with the NinePoint technology will supply the missing link and will enhance our clinical decision-making for these critically ill patients.”

This clearance marks another significant step for the strategic collaboration between NinePoint Medical and their exclusive worldwide distributor, Merit Medical Systems Inc. 

The pancreatico-biliary clearance marks a productive 12 months of product development activity for NinePoint Medical, according to the company. In November of 2018, NinePoint announced the first FDA-cleared artificial intelligence imaging technology for gastroenterology applications, the Intelligent Real-time Image Segmentation (IRIS) product. 

For more information: www.ninepointmedical.com

Related Content

NinePoint Medical Receives Additional FDA 510(k) Clearance for NvisionVLE Imaging System

Related Content

News | Ultrasound Imaging

September 24, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), recent European multisociety guidelines ...

Time September 24, 2021
arrow
News | Radiation Oncology

September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatment ...

Time September 21, 2021
arrow
News | RSNA

July 21, 2021 — Registration is now open for the Radiological Society of North America (RSNA) 107th Scientific Assembly ...

Time July 21, 2021
arrow
News | Interventional Radiology

July 8, 2021 — Fujifilm Medical Systems U.S.A., Inc. announced that the U.S. Food and Drug Administration (FDA) has ...

Time July 08, 2021
arrow
Feature | Mobile C-Arms | By Bhvita Jani

With the postponement of non-essential elective surgeries and medical procedures in 2020 to conserve medical resources ...

Time July 07, 2021
arrow
News | Interventional Radiology

May 6, 2021 — Omega Medical Imaging, an innovator in AI image-guided interventional systems for hospitals and healthcare ...

Time May 06, 2021
arrow
News | Radiology Business

May 3, 2021 — Asheville Radiology Associates announced the unveiling of a new brand including a name, logo and website ...

Time May 03, 2021
arrow
News | Interventional Radiology

March 25, 2021 — Boston Scientific Corporation announced positive data from the TARGET study of the TheraSphere Y-90 ...

Time March 25, 2021
arrow
News | Interventional Radiology

March 19, 2021 — Many women suffering significant postpartum bleeding continue to receive hysterectomies, rather than ...

Time March 19, 2021
arrow
News | Interventional Radiology

March 19, 2021 — A minimally invasive treatment for patients whose cancer has spread to their bones provides quick and ...

Time March 19, 2021
arrow
Subscribe Now